Most Read Contributor in Netherlands, February 2017
The Dutch Council of State has set out general rules for the
allocation of limited permits by public authorities in a recent
case involving gaming machine permits. These rules are: 1) limited
permits may, in principle, not be granted for an unlimited period
of time, and 2) the issuing authority must make an appropriate
disclosure about: the availability of the limited permits; how they
are allocated; when an application can be made; and what the
selection criteria are. Competition may be restricted, but not
This ruling clarifies the grounds on which companies can
challenge the granting of a limited permit to a competitor. But it
is also important for those receiving a limited permit to monitor
if the permit procedure meets the requirements set by the Council
of State. This way, the risk of the permit being annulled can be
Below are links to the Council of State ruling and the
accompanying press release (in Dutch only).
The competition law enforcement in Turkey is based on private and public enforcement pillars. TCA has sole discretion to enforce the Competition Act whereas the litigations initiated by the victims of anti-competitive conduct are seen in private courts.
Daiichi Sankyo İlaç Ticaret Ltd. Şti. ("Daiichi"), a globally active company in the distribution, sale, marketing and importation of pharmaceutical products, and Aksel Ecza Deposu A.Ş. ("Aksel"), a drug wholesaler, entered into a vertical exclusivity agreement ("Agreement").
The Competition Board concluded its investigation with regard to the booking services provided by Booking.com B.V. and by Bookingdotcom Destek Hizmetleri LLC, operating as the Turkish representative of Booking.com.
For the past few years, Turkey has tended to use various trade remedy tools more frequently, thus the number of investigations increases in depth and breadth with the aim of supporting domestic industry...
The CAT in the UK heard on 17 January 2017 an application by Flynn Pharma Ltd and Flynn Pharma (Holdings) Ltd to suspend the Competition and Markets Authority's direction to reduce the price of an epilepsy drug.
Some comments from our readers… “The articles are extremely timely and highly applicable” “I often find critical information not available elsewhere” “As in-house counsel, Mondaq’s service is of great value”
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).